Healthy Female Army
No Result
View All Result
  • Healthcare
  • Health and Medicine
  • Health News
  • Staying Healthy
  • Healthcare
  • Health and Medicine
  • Health News
  • Staying Healthy
No Result
View All Result
Healthy Female Army
No Result
View All Result
Home Healthcare

Distributor limiting allocation of low dose Wegovy

by
May 5, 2023
in Healthcare
0
Distributor limiting allocation of low dose Wegovy
0
SHARES
4
VIEWS
Share on FacebookShare on Twitter

Distributor Novo Nordisk has decided to limit low doses of obesity medication Wegovy in the U.S. as demand outpaces supply.

Novo Nordisk, a global healthcare and pharmaceutical company based in Denmark, is limiting the supply of Wegovy to conserve supply for patients already using the drug, the company said Thursday.

The company is still supplying “limited quantities” of 0.25-, 0.5- and 1-milligram doses to wholesalers for distribution to different retail pharmacies.

Wegovy was approved as a weight management treatment medication by the Food and Drug Administration in 2021.

The medication belongs to a class of drugs called GLP-1 agonists that have become popular in the weight loss industry, according to CBS News. Endorsements by celebrities on social media have only further fueled shortages nationwide.

“Today we are serving hundreds of thousands of U.S. patients with Wegovy,” the company said in a statement. “However, trends indicate that demand for Wegovy in the U.S. will exceed our current supply capacity.”

Previous Post

FDA recalls more than 500K COVID tests over bacteria risk

Next Post

Five key moments from Walensky’s tenure at CDC

Next Post
Five key moments from Walensky’s tenure at CDC

Five key moments from Walensky’s tenure at CDC

  • Trending
  • Comments
  • Latest
Vaccine protection against COVID-19 related issues

Vaccine protection against COVID-19 related issues

April 26, 2022
2 in 3 physicians concerned about AI driving diagnosis, treatment decisions: Survey

2 in 3 physicians concerned about AI driving diagnosis, treatment decisions: Survey

October 31, 2023
Religious services may lower risk of ‘deaths of despair’

Religious services may lower risk of ‘deaths of despair’

April 26, 2022
Signaling molecule may prevent Alzheimer’s

Signaling molecule may prevent Alzheimer’s

April 26, 2022
Trump’s advice to ‘Alligator Alcatraz’ escapees: ‘Don’t run in a straight line’

Trump’s advice to ‘Alligator Alcatraz’ escapees: ‘Don’t run in a straight line’

0
7 Tips to Make Your Workout Routine More Sustainable

7 Tips to Make Your Workout Routine More Sustainable

0
11 Weight Loss Tips That Will Get you Fast Results

11 Weight Loss Tips That Will Get you Fast Results

0
What are the Sunday Scaries? Plus, Here’s How to Beat Them

What are the Sunday Scaries? Plus, Here’s How to Beat Them

0
Trump’s advice to ‘Alligator Alcatraz’ escapees: ‘Don’t run in a straight line’

Trump’s advice to ‘Alligator Alcatraz’ escapees: ‘Don’t run in a straight line’

July 1, 2025
Senate megabill marks biggest Medicaid cuts in history 

Senate megabill marks biggest Medicaid cuts in history 

July 1, 2025
Democratic states sue Trump administration over school mental health funding cuts

Democratic states sue Trump administration over school mental health funding cuts

July 1, 2025
Gut microbes could offer protection from toxic ‘forever chemicals’: Study

Gut microbes could offer protection from toxic ‘forever chemicals’: Study

July 1, 2025

Recent News

Trump’s advice to ‘Alligator Alcatraz’ escapees: ‘Don’t run in a straight line’

Trump’s advice to ‘Alligator Alcatraz’ escapees: ‘Don’t run in a straight line’

July 1, 2025
Senate megabill marks biggest Medicaid cuts in history 

Senate megabill marks biggest Medicaid cuts in history 

July 1, 2025
Democratic states sue Trump administration over school mental health funding cuts

Democratic states sue Trump administration over school mental health funding cuts

July 1, 2025
Gut microbes could offer protection from toxic ‘forever chemicals’: Study

Gut microbes could offer protection from toxic ‘forever chemicals’: Study

July 1, 2025
  • Contact Us
  • Privacy Policy
  • Terms and Conditions
  • Email Whitelisting
  • Contact Us
  • Privacy Policy
  • Terms and Conditions
  • Email Whitelisting

Disclaimer: Healthyfemalearmy.com, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized beauty advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give health advice or provide beauty recommendation. Any recommendations here should be taken into consideration only after consulting with your doctor.
© 2025 Healthyfemalearmy.com. All rights reserved.

No Result
View All Result
  • Contact Us
  • Email Whitelisting
  • Home 1
  • Privacy Policy
  • Terms and Conditions
  • Terms and Conditions

Disclaimer: Healthyfemalearmy.com, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized beauty advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give health advice or provide beauty recommendation. Any recommendations here should be taken into consideration only after consulting with your doctor.
© 2025 Healthyfemalearmy.com. All rights reserved.